For citations:
Lila AM, Parfenov VA, Karateev AE, Adasheva TV, Alekseeva LI, Afanasyev VV, Barantsevich ER, Vorobyeva OV, Davydov OS, Ekusheva EV, Zagrebneva AI, Iskra DA, Kukushkin ML, Rachin AP, Filatova ES, Churyukanov MV, Shirokov VA. Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(1):116-123. (In Russ.) https://doi.org/10.14412/1996-7012-2025-1-116-123